HOME >> BIOLOGY >> NEWS
The Parkinson's Institute to conduct Phase III Clinical Trial of creatine for Parkinson's disease

The Parkinsons Institute will participate in a large-scale national clinical trial to learn if the nutritional supplement creatine can slow the progression of Parkinson's disease (PD). While creatine is not an approved therapy for PD or any other condition, it is widely thought to improve exercise performance. The potential benefit of creatine for PD was identified by Parkinsons researchers through a new rapid method for screening potential compounds. The trial, which begins today, is sponsored by the National Institutes of Health (NIH).

The double-blind, placebo-controlled, phase III study is one of the largest PD clinical trials to date. The Parkinsons Institute is one of 51 medical centers in the United States and Canada that will be recruiting patients as part of an effort to enroll 1720 people with early-stage PD.

"This study is an important step. We are pleased to have so many sites participating in this study, which may help us move more quickly toward developing a therapy that could change the course of this devastating disease," says Elias A. Zerhouni, M.D., director of the NIH. "The goal is to improve the quality of life for people with Parkinson's for a longer period of time than is possible with existing therapies." Currently there is no treatment that has been shown to slow the progression of PD.

The trial is the first large study in a series of NIH-sponsored clinical trials called NET-PD (NIH Exploratory Trials in Parkinson's Disease). The Parkinsons Institute has been affiliated with the program since 2002. The NIH has organized this large network of sites to allow researchers to work with PD patients over a long period of time, with a goal of finding effective and lasting treatments. NET-PD builds on a developmental research process from laboratory research to pilot studies in a select group of patients to the definitive phase III trial of effectiveness in people with PD.

"This study is an example
'"/>

Contact: Alicia Swanson
alicia.swanson@comcast.net
408-836-7170
The Parkinson's Institute
22-Mar-2007


Page: 1 2 3

Related biology news :

1. Scientists identify 2 distinct Parkinsons networks
2. Tracing Parkinsons lethal mechanism
3. Lancet study shows gene therapy for Parkinsons disease is safe and some patients benefit
4. Gene therapy study shows safety and statistically significant improvement in Parkinsons disease
5. PINK1 protects from Parkinsons
6. Parkinsons protein protects neurons from stress induced cell death
7. UCLA researchers discover link between Parkinsons and narcolepsy
8. Alzheimers, Parkinsons, type 2 diabetes similar at molecular level
9. Nanotechnology offers hope for treating spinal cord injuries, diabetes and Parkinsons disease
10. New studies link the environment to Parkinsons disease
11. NIH announces phase III clinical trial of creatine for Parkinsons disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/1/2020)... ... July 01, 2020 , ... Cure Glioblastoma, a registered 501(c)(3) ... and aggressive adult brain cancer—announced today the appointments of its first Senior Fellows: ... supporting the organization’s initiatives and overall vision. , "Senior Fellows are more than ...
(Date:6/28/2020)... ... ... In an upcoming episode scheduled for the fall of 2020, Advancements with Ted ... local listings for more info. , Today, the majority of testing is performed at ... the country. Results are then available several days later. Now, in an effort to ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... today announced that the company has received ISO9001:2015 certification for the development ... research industries. The decision to pursue ISO9001 accreditation demonstrates Kemp’s commitment to ...
Breaking Biology News(10 mins):
(Date:6/28/2020)... ... June 25, 2020 , ... With the COVID-19 pandemic impacting ... treatment. In an effort to better understand the cellular responses to COVID-19, the ... dataset portraying therapeutic compound effects from over 1,600 approved and referenced molecules on ...
(Date:6/23/2020)... (PRWEB) , ... June 22, 2020 , ... ... now offering an Amniosomes special offer. This includes buy three, get the fourth ... call (888) 568-6909. , Amniotic derived exosomes, known as exosomes, have been a ...
(Date:6/11/2020)... BALTIMORE (PRWEB) , ... June 09, 2020 , ... ... completion of Phase I of a Small Business Innovation Research (SBIR) program funded ... the 21st Century: Rapid Toxin Detection in the Field”. The project’s goal was ...
(Date:5/30/2020)... SAN FRANCISCO (PRWEB) , ... May 29, 2020 ... ... to pharmaceutical, biotech, medical device, diagnostics, and animal health markets, has enabled Cytovale, ... by applying cell mechanics and machine learning, to achieve their first patient in ...
Breaking Biology Technology:
Cached News: